Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Cytokinetics Inc. buy UBS Group AG

Cytokinetics Inc.
Start price
€34.60
03.04.23 / 50%
Target price
€56.02
03.04.24
Performance (%)
87.86%
End price
€65.00
04.04.24
Summary
This prediction ended on 04.04.24 with a price of €65.00. With a performance of 87.86% the BUY prediction by UBS_Group_AG was a big success. UBS_Group_AG has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Cytokinetics Inc. 0.000% 0.000% 75.872%
iShares Core DAX® 0.000% -2.064% 13.111%
iShares Nasdaq 100 0.626% -2.884% 37.744%
iShares Nikkei 225® 1.568% -5.892% 19.592%
iShares S&P 500 0.334% -2.281% 27.745%

Comments by UBS_Group_AG for this prediction

In the thread Discuss Cytokinetics Inc.
Prediction Buy
Perf. (%) 87.86%
Target price 56.022
Change
Ends at 03.04.24

Cytokinetics, Incorporated (NASDAQ: CYTK) had its price target lowered by analysts at UBS Group AG from $67.00 to $61.00. They now have a "buy" rating on the stock.
Ratings data for CYTK provided by MarketBeat

UBS Group AG 
0
Report Share
03.04.23
In the thread Trading Cytokinetics Inc.
Prediction Buy
Perf. (%) 87.86%
Target price 56.022
Change
Ends at 03.04.24

Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten

UBS Group AG 
0
Report Share
04.04.24